Find us on:

Research

Low dose naltrexone LDN: Harnessing the body's own chemistry to treat human ovarian cancer

Title
Low dose naltrexone LDN: Harnessing the body's own chemistry to treat human ovarian cancer
Publication Type
Journal Article
Research Type
Lab (in-vitro)
Reported as
Date
July 01, 2011
Authors
Goodman, SR
Institution
University of Texas
Link
Abstract

Article relating to Dr. Zagon et al.'s discovery of the ability of low dose naltrexone (LDN) to suppress progression of human ovarian cancer transplanted into mice.